IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 155 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $452,000 | -86.4% | 23,659 | -82.5% | 0.06% | -87.8% |
| Q3 2021 | $3,331,000 | -24.7% | 135,076 | -20.6% | 0.48% | -20.2% |
| Q2 2021 | $4,425,000 | +425.5% | 170,060 | +539.3% | 0.60% | +412.9% |
| Q1 2021 | $842,000 | +14.9% | 26,600 | +68.4% | 0.12% | +9.4% |
| Q4 2020 | $733,000 | -72.2% | 15,794 | -80.3% | 0.11% | -74.3% |
| Q3 2020 | $2,635,000 | +67.0% | 80,035 | +39.2% | 0.41% | +60.3% |
| Q2 2020 | $1,578,000 | +10.9% | 57,484 | +21.0% | 0.26% | -1.2% |
| Q1 2020 | $1,423,000 | +150.1% | 47,526 | -20.6% | 0.26% | +237.7% |
| Q1 2019 | $569,000 | – | 59,876 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |